Item banking and computer-adaptive testing in clinical trials: Standing in sight of the PROMISed land

Adam Smith, Andria Hanbury, Jenny Retzler

Research output: Contribution to journalArticle

Abstract

The use of patient-reported outcome instruments (PRO) in clinical trials in order to capture the impacts of treatment on patients is widespread. However, regulatory agencies have over the past decade highlighted the need for PROs that are fit for purpose and target relevant aspects of the patient's condition. Many legacy PROs were developed with little patient input, are lengthy, and may lack relevance having not been modified or adapted as medical treatments have advanced. Computer-adaptive test (CAT) systems provide the possibility of targeted approaches to capturing patient-centric data, while minimising patient burden. Coupled with greater patient input in the development of PROs, CAT offers the opportunity of overcoming the shortcomings of the previous generation of PROs. This paper describes the some of the issues facing legacy PROs, current regulatory guidance, and initiatives, such as the Patient-Reported Outcome Measurement Information System (PROMIS), as well as the early signs of use of CAT to capture PRO data in clinical trials.
LanguageEnglish
Article number100306
JournalContemporary Clinical Trials Communications
Volume13
Early online date17 Nov 2018
DOIs
Publication statusPublished - Mar 2019
Externally publishedYes

Fingerprint

Clinical Trials
Information Systems
Therapeutics
Patient Reported Outcome Measures

Cite this

@article{bb967df379834aeeaa9cc1fce2f66c0a,
title = "Item banking and computer-adaptive testing in clinical trials: Standing in sight of the PROMISed land",
abstract = "The use of patient-reported outcome instruments (PRO) in clinical trials in order to capture the impacts of treatment on patients is widespread. However, regulatory agencies have over the past decade highlighted the need for PROs that are fit for purpose and target relevant aspects of the patient's condition. Many legacy PROs were developed with little patient input, are lengthy, and may lack relevance having not been modified or adapted as medical treatments have advanced. Computer-adaptive test (CAT) systems provide the possibility of targeted approaches to capturing patient-centric data, while minimising patient burden. Coupled with greater patient input in the development of PROs, CAT offers the opportunity of overcoming the shortcomings of the previous generation of PROs. This paper describes the some of the issues facing legacy PROs, current regulatory guidance, and initiatives, such as the Patient-Reported Outcome Measurement Information System (PROMIS), as well as the early signs of use of CAT to capture PRO data in clinical trials.",
author = "Adam Smith and Andria Hanbury and Jenny Retzler",
year = "2019",
month = "3",
doi = "10.1016/j.conctc.2018.11.005",
language = "English",
volume = "13",
journal = "Contemporary Clinical Trials Communications",
issn = "2451-8654",
publisher = "Elsevier Inc.",

}

Item banking and computer-adaptive testing in clinical trials : Standing in sight of the PROMISed land. / Smith, Adam; Hanbury, Andria; Retzler, Jenny.

In: Contemporary Clinical Trials Communications, Vol. 13, 100306, 03.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Item banking and computer-adaptive testing in clinical trials

T2 - Contemporary Clinical Trials Communications

AU - Smith, Adam

AU - Hanbury, Andria

AU - Retzler, Jenny

PY - 2019/3

Y1 - 2019/3

N2 - The use of patient-reported outcome instruments (PRO) in clinical trials in order to capture the impacts of treatment on patients is widespread. However, regulatory agencies have over the past decade highlighted the need for PROs that are fit for purpose and target relevant aspects of the patient's condition. Many legacy PROs were developed with little patient input, are lengthy, and may lack relevance having not been modified or adapted as medical treatments have advanced. Computer-adaptive test (CAT) systems provide the possibility of targeted approaches to capturing patient-centric data, while minimising patient burden. Coupled with greater patient input in the development of PROs, CAT offers the opportunity of overcoming the shortcomings of the previous generation of PROs. This paper describes the some of the issues facing legacy PROs, current regulatory guidance, and initiatives, such as the Patient-Reported Outcome Measurement Information System (PROMIS), as well as the early signs of use of CAT to capture PRO data in clinical trials.

AB - The use of patient-reported outcome instruments (PRO) in clinical trials in order to capture the impacts of treatment on patients is widespread. However, regulatory agencies have over the past decade highlighted the need for PROs that are fit for purpose and target relevant aspects of the patient's condition. Many legacy PROs were developed with little patient input, are lengthy, and may lack relevance having not been modified or adapted as medical treatments have advanced. Computer-adaptive test (CAT) systems provide the possibility of targeted approaches to capturing patient-centric data, while minimising patient burden. Coupled with greater patient input in the development of PROs, CAT offers the opportunity of overcoming the shortcomings of the previous generation of PROs. This paper describes the some of the issues facing legacy PROs, current regulatory guidance, and initiatives, such as the Patient-Reported Outcome Measurement Information System (PROMIS), as well as the early signs of use of CAT to capture PRO data in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85058518968&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2018.11.005

DO - 10.1016/j.conctc.2018.11.005

M3 - Article

VL - 13

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

SN - 2451-8654

M1 - 100306

ER -